Search Results - "van Heumen, Bjorn W.H."

Surgical management for advanced duodenal adenomatosis and duodenal cancer in Dutch patients with familial adenomatous polyposis: A nationwide retrospective cohort study by van Heumen, Bjorn W.H., MD, Nieuwenhuis, Marry H., MD, van Goor, Harry, MD, PhD, Mathus-Vliegen, Lisbeth (E) M.H., MD, PhD, Dekker, Evelien, MD, PhD, Gouma, Dirk J., MD, PhD, Dees, Jan, MD, PhD, van Eijck, Casper H.J., MD, PhD, Vasen, Hans F.A., MD, PhD, Nagengast, Fokko M., MD, PhD

“…Background Duodenal cancer is a major cause of mortality in patients with familial adenomatous polyposis (FAP). The clinical challenge is to perform…”
Get full text

Celecoxib and tauro-ursodeoxycholic acid co-treatment inhibits cell growth in familial adenomatous polyposis derived LT97 colon adenoma cells by van Heumen, Bjorn W.H., Roelofs, Hennie M.J., te Morsche, René H.M., Marian, Brigitte, Nagengast, Fokko M., Peters, Wilbert H.M.

“…Chemoprevention would be a desirable strategy to avoid duodenectomy in patients with familial adenomatous polyposis (FAP) suffering from duodenal adenomatosis…”
Get full text

Over-expression of COX-2 mRNA in colorectal cancer by Roelofs, Hennie M J, Te Morsche, Rene H M, van Heumen, Bjorn W H, Nagengast, Fokko M, Peters, Wilbert H M

“…Cyclooxygenase-2 (COX-2, PTGS2) is an enzyme involved in the synthesis of prostaglandins and thromboxanes, which are regulators of biologic processes such as…”
Get full text

Influence of Curcumin, Quercetin, and Eicosapentaenoic Acid on the Expression of Phase II Detoxification Enzymes in the Intestinal Cell Lines HT-29, Caco-2, HuTu 80, and LT97 by Odenthal, Julia, van Heumen, Bjorn W. H, Roelofs, Hennie M. J, te Morsche, Rene H. M, Marian, Brigitte, Nagengast, Fokko M, Peters, Wilbert H. M

“…Curcumin, quercetin, and eicosapentaenoic acid (EPA) are 3 natural compounds with the capacity to reduce adenoma burden in patients with familial adenomatous…”
Get full text

Management of Sporadic Duodenal Adenomas and the Association With Colorectal Neoplasms: A Retrospective Cohort Study by van Heumen, Bjorn W H, Mul, Karlien, Nagtegaal, Iris D, van Kouwen, Mariëtte C A, Nagengast, Fokko M

“…GOALS:To evaluate management, outcome, and follow-up of patients with sporadic duodenal adenomas and assess the presence of colorectal neoplasms…”
Get full text

Duodenal mucosal risk markers in patients with familial adenomatous polyposis: effects of celecoxib/ursodeoxycholic acid co-treatment and comparison with patient controls by van Heumen, Bjorn W H, Roelofs, Hennie M J, te Morsche, René H M, Nagengast, Fokko M, Peters, Wilbert H M

“…Familial adenomatous polyposis (FAP) is a disease characterized by the development of hundreds to thousands of adenomatous polyps in the colorectum early in…”
Get full text

Effects of intervention with sulindac and inulin/VSL#3 on mucosal and luminal factors in the pouch of patients with familial adenomatous polyposis by Friederich, Pieter, Verschuur, Jelle, van Heumen, Bjorn W. H., Roelofs, Hennie M. J., Berkhout, Marloes, Nagtegaal, Iris D., van Oijen, Martijn G. H., van Krieken, Johannes H. J. M., Peters, Wilbert H. M., Nagengast, Fokko M.

“…Background/aim In order to define future chemoprevention strategies for adenomas or carcinomas in the pouch of patients with familial adenomatous polyposis…”
Get full text